No connection

Search Results

GKOS vs UNH

GKOS
Glaukos Corporation
NEUTRAL
Price
$122.07
Market Cap
$7.14B
Sector
Healthcare
AI Confidence
80%
UNH
UnitedHealth Group Incorporated
NEUTRAL
Price
$323.48
Market Cap
$293.61B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
GKOS
--
UNH
24.43
Forward P/E
GKOS
282.75
UNH
16.08
P/B Ratio
GKOS
10.7
UNH
3.11
P/S Ratio
GKOS
14.08
UNH
0.66
EV/EBITDA
GKOS
-142.15
UNH
16.47

Profitability

Gross Margin
GKOS
77.96%
UNH
18.53%
Operating Margin
GKOS
-18.87%
UNH
0.34%
Profit Margin
GKOS
-36.99%
UNH
2.69%
ROE
GKOS
-26.38%
UNH
12.54%
ROA
GKOS
-5.8%
UNH
3.9%

Growth

Revenue Growth
GKOS
35.7%
UNH
12.3%
Earnings Growth
GKOS
--
UNH
-99.9%

Financial Health

Debt/Equity
GKOS
0.16
UNH
0.82
Current Ratio
GKOS
4.69
UNH
0.79
Quick Ratio
GKOS
3.83
UNH
0.7

Dividends

Dividend Yield
GKOS
--
UNH
2.73%
Payout Ratio
GKOS
0.0%
UNH
65.99%

AI Verdict

GKOS NEUTRAL

GKOS presents a dichotomy between strong operational growth and extreme valuation. The Piotroski F-Score of 5/9 indicates a stable financial foundation, supported by an exceptional current ratio of 4.69 and very low debt/equity (0.16). However, the company remains unprofitable with a negative profit margin of -36.99% and a staggering forward P/E of 282.75. While revenue growth is robust at 35.7%, the bearish insider sentiment and weak technical trend suggest a disconnect between analyst optimism and internal confidence.

Strengths
Strong revenue growth (35.7% YoY)
Excellent liquidity with a current ratio of 4.69
High gross margins (77.96%) indicating strong product pricing power
Risks
Extreme valuation metrics (Forward P/E 282.75, P/S 14.08)
Persistent lack of profitability over 25 consecutive quarters
Bearish insider activity with $6.41M in sales and zero buys
UNH NEUTRAL

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.

Strengths
Strong consistent revenue growth (12.3% YoY)
Manageable Debt/Equity ratio of 0.82
Attractive Forward P/E (16.08) compared to current P/E (24.43)
Risks
Extreme earnings volatility (YoY Earnings Growth -99.9%)
Poor liquidity indicated by a Current Ratio of 0.79
Extremely thin operating margins (0.34%)

Compare Another Pair

GKOS vs UNH: Head-to-Head Comparison

This page compares Glaukos Corporation (GKOS) and UnitedHealth Group Incorporated (UNH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile